Aarti Drugs Ltd: Financial Results for Year Ended March 31, 2026

Aarti Drugs Ltd. announced its financial results for the quarter and year ended March 31, 2026, following a Board of Directors meeting on May 15, 2026. The board approved audited standalone and consolidated financial results, including statements of assets, liabilities, cash flow, and auditor's reports. Additionally, M/s GMVP & Associates LLP was re-appointed as Cost Auditor for FY 2026-27, and M/s Raman S. Shah & Co. was re-appointed as Internal Auditor for three years starting April 1, 2026. The Risk Management Committee was also re-constituted with the inclusion of Shri Narendra J. Salvi.